newsfilter
← Latest News
Business Wire·

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

MIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions Bruker Corporation (NASDAQ:BRKR) today announced a majority investment in